Loading…
Tuesday April 29, 2025 1:00pm - 2:00pm PDT
  • Discover how Medical Affairs drives a comprehensive approach to product development
  • Explore the transformative impact of Medical Affairs throughout every stage of a product’s lifecycle
  • Learn strategic approaches to fostering innovation and prioritizing future-focused investments
Moderators
avatar for Allison Trucillo, MD

Allison Trucillo, MD

Vice President, Medical Affairs, Avalyn Pharma
Speakers
avatar for William Go, MD, Ph.D.

William Go, MD, Ph.D.

Chief Medical Officer, A2 Biotherapeutics
William Go, M.D., Ph.D., oversees all aspects of A2 Bio’s development of T cell therapies utilizing the company’s novel platform technology.Previously, Will worked at Kite Pharma (acquired by Gilead) where he developed novel immune-cellular therapies for the treatment of cancer... Read More →
avatar for Amreen Husain, MD

Amreen Husain, MD

Chief Medical Officer, RayzeBio
Amreen Husain, MD is an accomplished physician and drug developer who brings more than a decade of experience across large pharma and small biotech. Her extensive experience in oncology drug development spans all phases and multiple therapeutic areas and modalities including immuno-oncology... Read More →
avatar for Steven Zhang, MD, PhD

Steven Zhang, MD, PhD

Chief Medical Officer, Thea Pharma
Tuesday April 29, 2025 1:00pm - 2:00pm PDT
Town & Country Ballroom C Town & Country Resort, 500 Hotel Cir N, San Diego, CA 92108, USA

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link